Across TCGA pan-cancer cohorts, RNA5SP26 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNA5SP26 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RNA5SP26 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP26 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

CESC, BRCA, and KIRC are the cancer types where RNA5SP26 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.146	0.798	<.001	108	view →
BRCA	OS	Tertile	All	0.135	0.579	.003	48	view →
KIRC	DFS	Tertile	IV	0.217	0.603	.013	18	view →
ESCA	OS	Tertile	III,IV	1.000	0.372	.033	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNA5SP26 tumor-vs-normal RNA expression · all RNA5SP26 data types